Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Sun Pharma and feels that all banking stocks are sell ideas.
Ashwani Gujral of ashwanigujral.com recommends selling Strides Shasun, Torrent Pharma and Aurobindo Pharma and feels that ITC may head lower and test Rs 260.
Ashwani Gujral of ashwanigujral.com recommends selling Asian Paints and Wockhardt and advises buying Hindustan Unilever, Lupin and IndusInd Bank.
Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma, Cairn India, Tata Steel, Bank of Baroda and Torrent Pharma.
Sudarshan Sukhani of s2analytics.com recommends buying Torrent Pharma and Hindustan Unilever and advises selling BEML.
Ashwani Gujral of ashwanigujral.com is of the view that one may buy Adani Port, Aurobindo Pharma, BPCL, Torrent Pharma and Kotak Mahindra Bank.
Ashwani Gujral of ashwanigujral.com recommends selling Torrent Pharma and Voltas and advises buying Bank of Baroda.
Dipan Mehta, Member at BSE & NSE is of the view that there are opportunities in pharma stocks and feels that Alembic Pharma looks interesting.
Sudip Bandopadhyay, Market Expert is of the view that one can buy Bharat Forge, Mindtree and Persistent Systems.
Gaurav Bissa of LKP Securities recommends going long in Torrent Pharma with a target of Rs 1480.
According to Gaurang Shah of Geojit BNP Paribas Financial Services, one may hold Torrent Pharma.
The brokerage says higher Abilify sales, Dahej addressing capacity constraints and 10 percent price increase in Elder portfolio are key. According to Credit Suisse important markets of Torrent Pharma in order of priority are India, the US, Brazil and Germany.
Sudip Bandopadhyay, Market Expert recommends buying Persistent Systems.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Infosys, Gammon India, GMR Infra, Dishman Pharmaceuticals and Chemicals, Torrent Pharmaceuticals, SpiceJet, Indigo & Jet Airways.
Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Aurobindo Pharma, Cadila Healthcare and Torrent Pharmaceuticals from pharmaceutical space.
SP Tulsian of sptulsian.com is of the view that one may see Samkrg Pistons and Rings test Rs 300.
Dipan Mehta, Member at BSE & NSE is of the view that one can add selective banks, auto, pharma and FMCG stocks in the portfolio.
CA Rudramurthy BV of Vachana Investments is of the view that one may buy Wonderla with a target of Rs 332.
Dipan Mehta, Member at BSE & NSE is of the view that one can invest in Alembic Pharma.
R Venkatraman, MD at IIFL Group likes Tata Consultancy Services and Infosys in IT space, Maruti Suzuki and Tata Motors from the auto space and Sun Pharmaceutical Industries and Torrent Pharmaceuticals from the pharma space.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Indiabulls Real Estate, Mphasis, Federal Bank, Torrent Pharma, Dr Reddys Laboratories & Aurobindo Pharma.
Hemen Kapadia of KR Choksey Securities is of the view that one may expect upside in Torrent Pharma.
Mehraboon Irani of Nirmal Bang Securities is of the view that Dr Reddy's Labs is the top pick.
According to Nooresh Merani of Analyse India, one may hold Torrent Pharma.
Deepak Shenoy of capitalmind.in has a positive stance on Sun Pharmaceutical Industries and Strides Arcolab.